The Indian Institute of Technology (IIT) Madras is partnering with the Ministry of Ayush, Government of India, to organise a six-day Continuing Medical Education (CME) programme on ‘Technological interventions to standardise the indigenous system of medicine in India’ called AYURTECH 2022-CME, from June 20 to June 25.
The programme is sponsored by the Ministry of Ayush, Government of India.
The IIT Madras Department of Biotechnology aims to provide a forum for AYUSH scientists and researchers to hear from experts in academia and industry and to get an overview of the expanding field of AYUSH sciences. It is also a platform to network, share and showcase one’s research findings among peers from industry and academia, including technical institutes, industry, AYUSH colleges and hospitals for prospective collaborations.
The programme includes lectures by experts from academia and industry across the country followed by a hands-on workshop exclusively designed for CME participants, who are nominees from the nodal research and academic centres under the Ministry of AYUSH.
The Biotechnology department is also organising a lecture series open to students, academics and industry working on AYUSH sciences and natural products to create increased awareness and promote interest for interdisciplinary research and education in the field of AYUSH.
Addressing the inaugural session of the combined inaugural event of AYURTECH 2022-CME and the IIT-M AYURTECH 2022-Lecture series, Manoj Nesari, adviser, Ministry of Ayush, Government of India, said, “The Ministry of Ayush is working keenly to implement the United Nations Sustainable Development Goals and the National Health Policy, 2017. Hence, there is a huge scope to integrate technology and AYUSH.”
Dignitaries for the IITM AYURTECH 2022-Lecture series include Ranganathan Raghavan, general manager, research, Cytiva; and U.V. Babu, head (R&D), Himalaya Drug Company.
The interactive lecture series broadly covered the areas of Applied Plant Biotechnology, Medicinal Chemistry, Bioinformatics and Biological Sciences. Eminent scientists, faculty and researchers actively working in allied areas, who are affiliated to various national-level Institutes of repute and industry were speakers for the two events.
“There is a huge need for Indian medicines to have the technological support to take them to the next level. This will provide empirical and scientific evidence for Indian medicines. There is a need to focus on research that will lead to filing more patents for Indian medicines,” said V. Kamakoti, director, IIT Madras.